Flow cytometry evaluation of the T-cell receptor V β repertoire among HIV-1 infected individuals before and after antiretroviral therapy

Journal of Clinical Immunology

Volumn 25, Issue 2, 2005, Pages 116-126

  Giacoia Gripp, Carmem Beatriz Wagner ^a   Neves Jr , Ivan ^b   Galhardo, Maria Clara ^b   Morgado, Mariza Gonçalves ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

Author keywords

Clonality; HAART; HIV 1; Repertoire; TCR V

Indexed keywords

ANTIRETROVIRUS AGENT; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; TIME FACTORS; TREATMENT OUTCOME;

EID: 17744384921     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10875-005-2817-z     Document Type: Article

References (51)

1. Soudeyns H, Pantaleo G: The moving target: mechanisms of HIV persistence during primary infection. Immunol Today 20:446-450, 1999
2. Graziosi C, Soudeyns H, Rizzardi GP, Bart PA, Chapuis A, Pantaleo G: Immunopathogenesis of HIV infection. AIDS Res Hum Retroviruses Suppl 2:S135-S142, 1998
3. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68:4650-4655, 1994
4. Moore JP, Cao Y, Ho DD, Koup RA: Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1. J Virol 68:5142-5155, 1994
5. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC: Brief report: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. New Engl J Med 26(332):228-232, 1995
6. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen OJ, Demarest JF, Montefiori D, Orenstein JM, Fox C, Schrager LK, Margolick JB, Buchbinder S, Giorgi JV, Fauci AS: Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. New Engl J Med 26(332):209-216, 1995
7. Haynes BF, Pantaleo G, Fauci AS: Toward an understanding of the correlates of protective immunity to HIV infection. Science 271:324-328, 1996
8. Pantaleo G, Fauci AS: New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol 13:487-512, 1995
9. Propato A, Schiaffella E, Vicenzi E, Francavilla V, Baloni L, Paroli M, Finocchi L, Tanigaki N, Ghezzi S, Ferrara R, Chesnut R, Livingston B, Sette A, Paganelli R, Aiuti F, Poli G, Barnaba V: Spreading of HIV-specific CD8+ T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity. Hum Immunol 62:561-576, 2001
10. Bodman-Smith MD, Williams I, Johnstone R, Boylston A, Lydyard PM, Zumla A. T cell receptor usage in patients with non-progressing HIV infection. Clin Exp Immunol 130:115-120, 2002
11. Pantaleo G, Demarest JF, Soudeyns H, Graziosi C, Denis F, Adelsberger JW, Borrow P, Saag MS, Shaw GM, Sekaly RP, Fauci AS: Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370:463-467, 1994
12. Pantaleo G, Demarest JF, Schacker T, Vaccarezza M, Cohen OJ, Daucher M, Graziosi C, Schnittman SS, Quinn TC, Shaw GM, Perrin L, Tambussi G, Lazzarin A, Sekaly RP, Soudeyns H, Corey L, Fauci AS: The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci USA 94:254-258, 1997
13. Chen ZW, Shen L, Regan JD, Kou Z, Ghim SH, Letvin NL: The T cell receptor gene usage by simian immunodeficiency virus gag-specific cytotoxic T lymphocytes in rhesus monkeys. J Immunol 156:1469-1475, 1996
14. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New Engl J Med 338:853-860, 1998
15. Valdez H, Chowdhry TK, Asaad R, Woolley IJ, Davis T, Davidson R, Beinker N, Gripshover BM, Salata RA, McComsey G, Weissman SB, Lederman MM: Changing spectrum of mortality due to human immunodeficiency virus: Analysis of 260 deaths during 1995-1999. Clin Infect Dis 32:1487-1493, 2001
16. Collier AC, Coombs RW, Schoenfeld DA, Bassett RL, Timpone J, Baruch A, Jones M, Facey K, Whitacre C, McAuliffe VJ, Friedman HM, Merigan TC, Reichman RC, Hooper C, Corey L: Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. New Engl J Med 334:1011-1017, 1996
17. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J: Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277:112-116, 1997
18. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, Emini EA, Chodakewitz JA: Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. New Engl J Med 337:734-739, 1997
19. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ Jr, Feinberg JE, Balfour HH Jr, Deyton LR, Chodakewitz JA, Fischl MA: A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. New Engl J Med 337:725-733, 1997
20. Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB: Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 11:1731-1738, 1997
21. Egger M, Hirschel B, Francioli P, Sudre P, Wirz M, Flepp M, Rickenbach M, Malinverni R, Vernazza P, Battegay M: Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study. Swiss HIV Cohort Study. BMJ 315:1194-1199, 1997
22. Ledergerber B, Telenti A, Egger M: Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study. Swiss HIV Cohort Study. BMJ 319:23-24, 1999
23. Pakker NG, Notermans DW, de Boer RJ, Roos MT, de Wolf F, Hill A, Leonard JM, Danner SA, Miedema F, Schellekens PT: Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation. Nat Med 4:208-214, 1998
24. Bisset LR, Cone RW, Huber W, Battegay M, Vernazza PL, Weber R, Grob PJ, Opravil M: Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study. AIDS 12:2115-2123, 1998
25. Bouscarat F, Levacher M, Landman R, Muffat-Joly M, Girard PM, Saimot AG, Brun-Vezinet F, Sinet M: Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy. AIDS 12:1267-1273, 1998
26. Connick E, Lederman MM, Kotzin BL, Spritzler J, Kuritzkes DR, St Clair M, Sevin AD, Fox L, Chiozzi MH, Leonard JM, Rousseau F, D'Arc Roe J, Martinez A, Kessler H, Landay A: Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologie response. J Infect Dis 181:358-363, 2000
27. Soudeyns H, Campi G, Rizzardi GP, Lenge C, Demarest JF, Tambussi G, Lazzarin A, Kaufmann D, Casorati G, Corey L, Pantaleo G: Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality. Blood 95:1743-1751, 2000
28. Plana M, Garcia F, Gallart T, Miro JM, Gatell JM: Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease. Immunology Study Group of Spanish EARTH-1 Study. Lancet 352:1194-1195, 1998
29. Pontesilli O, Kerkhof-Garde S, Notermans DW, Foudraine NA, Roos MT, Klein MR, Danner SA, Lange JM, Miedema F: Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy. J Infect Dis 180:76-86, 1999
30. Al-Harthi L, Siegel J, Spritzler J, Pottage J, Agnoli M, Landay A: Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease. AIDS 14:761-770, 2000
31. Haslett PA, Nixon DF, Shen Z, Larsson M, Cox WI, Manandhar R, Donahoe SM, Kaplan G: Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy. J Infect Dis 181:1264-1272, 2000
32. Ruiz L, Martinez-Picado J, Romeu J, Paredes R, Zayat MK, Marfil S, Negredo E, Sirera G, Tural C, Clotet B: Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression. AIDS 14:397-403, 2000
33. MacIsaac C, Curtis N, Cade J, Visvanathan K: Rapid analysis of the Vbeta repertoire of CD4 and CD8 T lymphocytes in whole blood. J Immunol Methods 283:9-15, 2003
34. Choi YW, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J: Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci USA 86:8941-8945, 1989
35. Malhotra U, Spielman R, Concannon P. Variability in T cell receptor V beta gene usage in human peripheral blood lymphocytes. Studies of identical twins, siblings, and insulin-dependent diabetes mellitus patients. J Immunol 149:1802-1808, 1992
36. Cossarizza A, Kahan M, Ortolani C, Franceschi C, Londei M: Preferential expression of V beta 6.7 domain on human peripheral CD4+ T cells. Implication for positive selection of T cells in man. Eur J Immunol 21:1571-1574, 1991
37. Grunewald J, Janson CH, Wigzell H: Biased expression of individual T cell receptor V gene segments in CD4+ and CD8+ human peripheral blood T lymphocytes. Eur J Immunol 21:819-822, 1991
38. Clarke GR, Humphrey CA, Lancaster FC, Boylston AW: The human T cell antigen receptor repertoire: Skewed use of V beta gene families by CD8+ T cells. Clin Exp Immunol 96:364-369, 1994
39. Muraro PA, Jacobsen M, Necker A, Nagle JW, Gaber R, Sommer N, Oertel WH, Martin R, Hemmer B: Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vbeta analysis. J Immunol Methods 246:131-143, 2000
40. van den Beemd R, Boor PP, van Lochem EG, Hop WC, Langerak AW, Wolvers-Tettero IL, Hooijkaas H, van Dongen JJ: Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 40:336-345, 2000
41. Melenhorst JJ, Eniafe R, Follmann D, Nakamura R, Kirby M, Barrett AJ: Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndrome. Br J Haematol 119:97-105, 2002
42. Shigematsu M, Nagai S, Mikuniya T, Izumi T, Wigzell H, Eklund AG, Grunewald J: T cell receptor (TCR) V gene segment use in HLA-typed Japanese healthy subjects. Clin Exp Immunol 103:149-154, 1996
43. Esin S, Gul A, Hodara V, Jeddi-Tehrani M, Dilsen N, Konice M, Andersson R, Wigzell H: Peripheral blood T cell expansions in patients with Behcet's disease. Clin Exp Immunol 107:520-527, 1997
44. Akolkar PN, Gulwani-Akolkar B, Pergolizzi R, Bigler RD, Silver J: Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. J Immunol 150:2761-2773, 1993
45. Akolkar PN, Gulwani-Akolkar B, Robinson MA, Silver J: The influence of non-HLA genes on the human T-cell receptor repertoire. Scand J Immunol 42:248-256, 1995
46. Silver J, Gulwani-Akolkar B, Akolkar PN: The influence of genetics, environment, and disease state on the human T-cell receptor repertoire. Ann N Y Acad Sci 756:28-52, 1995
47. Mion M, Indraccolo S, Feroli F, Minuzzo S, Masiero S, Zamarchi R, Barelli A, Borri A, Chieco-Bianchi L, Amadori A: TCR expression and clonality analysis in peripheral blood and lymph nodes of HIV-infected patients. Hum Immunol 57:93-103, 1997
48. Pantaleo G, Soudeyns H, Demarest JF, Vaccarezza M, Graziosi C, Paolucci S, Daucher MB, Cohen OJ, Denis F, Biddison WE, Sekaly RP, Fauci AS: Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. Proc Natl Acad Sci USA 94:9848-9853, 1997
49. Soudeyns H, Rebai N, Pantaleo GP, Ciurli C, Boghossian T, Sekaly RP, Fauci AS: The T cell receptor V beta repertoire in HIV-1 infection and disease. Semin Immunol 5:175-185, 1993
50. Giovannetti A, Pierdominici M, Marziali M, Mazzetta F, Caprini E, Russo G, Bugarini R, Bernardi ML, Mezzaroma I, Aiuti F: Persistently biased T-cell receptor repertoires in HIV-1-infected combination antiretroviral therapy-treated patients despite sustained suppression of viral replication. J Acquir Immune Defic Syndr 34:140-154, 2003
51. Cossarizza A, Poccia F, Agrati C, D'Offizi G, Bugarini R, Pinti M, Borghi V, Mussini C, Esposito R, Ippolito G, Narciso P: Highly active antiretroviral therapy restores CD4+ Vbeta T-cell repertoire in patients with primary acute HIV infection but not in treatment-naive HIV+ patients with severe chronic infection. J Acquir Immune Defic Syndr 35:213-222, 2004